Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Net Margin (2016 - 2020)

Syndax Pharmaceuticals (SNDX) has 6 years of Net Margin data on record, last reported at 5226.32% in Q4 2020.

  • For Q4 2020, Net Margin fell 148816.0% year-over-year to 5226.32%; the TTM value through Sep 2021 reached 5226.32%, down 89092.0%, while the annual FY2025 figure was 165.6%, 118050.0% up from the prior year.
  • Net Margin reached 5226.32% in Q4 2020 per SNDX's latest filing, roughly flat from 5238.26% in the prior quarter.
  • Across five years, Net Margin topped out at 1594.89% in Q4 2017 and bottomed at 5238.26% in Q3 2020.
  • Average Net Margin over 5 years is 4162.47%, with a median of 4309.0% recorded in 2017.
  • Peak YoY movement for Net Margin: surged 3175379bps in 2016, then crashed -349274bps in 2018.
  • A 5-year view of Net Margin shows it stood at 3564.92% in 2016, then soared by 55bps to 1594.89% in 2017, then crashed by -219bps to 5087.63% in 2018, then grew by 27bps to 3738.16% in 2019, then tumbled by -40bps to 5226.32% in 2020.
  • Per Business Quant database, its latest 3 readings for Net Margin were 5226.32% in Q4 2020, 5238.26% in Q3 2020, and 4382.59% in Q2 2020.